These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9111563)

  • 1. Infection with hepatitis G virus in immunoglobulin recipients.
    Berger A; Scharrer I; Doerr HW; Hess G; Weber B
    Lancet; 1997 Jan; 349(9046):207. PubMed ID: 9111563
    [No Abstract]   [Full Text] [Related]  

  • 2. Infection with hepatitis G virus in immunoglobulin recipients.
    Lefrère JJ; Ravera N; Corbi C; Mariotti M; Loiseau P
    Lancet; 1997 Jan; 349(9046):206. PubMed ID: 9111561
    [No Abstract]   [Full Text] [Related]  

  • 3. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
    Berger A; Doerr HW; Scharrer I; Weber B
    J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GB virus C/hepatitis G virus and intravenous immunoglobulins.
    Nübling C; Gröner A; Löwer J
    Vox Sang; 1998; 75(3):189-92. PubMed ID: 9852405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection with hepatitis G virus in immunoglobulin recipients.
    Vento S; Renzini C; Casali F; Ferraro T; Concia E
    Lancet; 1997 Jan; 349(9046):206-7. PubMed ID: 9111562
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus.
    Tan D; Matsumoto A; Conry-Cantilena C; Melpolder JC; Shih JW; Leuther M; Hess G; Gibble JW; Ness PM; Alter HJ
    J Infect Dis; 1999 May; 179(5):1055-61. PubMed ID: 10191204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of intravenous immunoglobulin preparations.
    Weisman LE
    Isr J Med Sci; 1994; 30(5-6):459-63. PubMed ID: 8034504
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis G virus in intramuscular and intravenous immunoglobulin products manufactured in Europe.
    Cristiano K; Pisani G; Wirz M; Gentili G
    Transfusion; 1999 Apr; 39(4):428. PubMed ID: 10220272
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis G virus in intravenous immunoglobulin.
    Chen PJ; Kao JH; Chen DS
    Gastroenterology; 1996 Nov; 111(5):1399-400. PubMed ID: 8898661
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis G virus infection.
    Schleicher S; Normann A; Gregor M; Hess G; Flehmig B
    Lancet; 1997 Mar; 349(9056):954-5. PubMed ID: 9093274
    [No Abstract]   [Full Text] [Related]  

  • 13. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
    Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
    N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users.
    Zehender G; De Maddalena C; Bosisio AB; Gianotto M; Santambrogio S; Moroni M; Galli M
    J Hum Virol; 1998; 1(2):96-100. PubMed ID: 10195238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of hepatitis G virus RNA and antibody to probable viral envelope protein but not both in AIDS patients' plasma.
    Woolley I; Valdez H; Walker C; Landay A; Zdunek D; Hess G; Lederman MM
    AIDS; 1998 Mar; 12(5):530-1. PubMed ID: 9543453
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of GB virus C/hepatitis G virus ribonucleic acid and anti-hepatitis G virus-E2 antibodies among Japanese children with histories of transfusions or with liver diseases.
    Goto K; Sugiyama K; Li R; Miyake Y; Ando T; Mizutani F; Terabe K; Mizuno K; Wada Y
    Pediatr Res; 1999 Jan; 45(1):128-32. PubMed ID: 9890620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis G virus exists--but does hepatitis G?].
    Wejstål R; Lindberg J
    Lakartidningen; 1999 Jan; 96(4):323-6. PubMed ID: 10024820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coexistent hepatitis G virus infection and autoimmune hepatitis].
    Szaflarska-Szczepanik A
    Pol Merkur Lekarski; 1999 Feb; 6(32):82-3. PubMed ID: 10337178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users.
    Anastassopoulou CG; Paraskevis D; Sypsa V; Psichogiou M; Katsoulidou A; Tassopoulos N; Skoutelis A; Malliori M; Hatzakis A
    J Med Virol; 1998 Nov; 56(3):246-52. PubMed ID: 9783693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term liver function of recipients with hepatitis G virus infection after bone marrow transplantation.
    Maruta A; Tanabe J; Hashimoto C; Kato K; Kanamori H; Fukawa H; Miyashita H; Fujisawa S; Fujita H; Matsuzaki M; Motomura S; Kodama F; Ookawa S; Mohri H; Ishigatsubo Y
    Bone Marrow Transplant; 1999 Aug; 24(4):359-63. PubMed ID: 10467323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.